Thalamic syndrome improves 20 years after stroke following treatment at the INR, Sept. 2018

Improvement in neurological signs and symptoms of thalamic syndrome (Dejerine-Roussy Syndrome) due to a stroke 20 years previously (in 1998) after treatment at the Institute of Neurological Recovery in Boca Raton in September 2018, by Edward Tobinick, M.D. Text, images and video © 2018, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Immediate improvement in aphasia, apraxia and gait 2 yrs. after stroke at the INR, Sept 2018 4K

Immediate neurological recovery after treatment at the Institute of Neurological Recovery, September 14, 2018, two years after stroke. Improvements noted in speech, aphasia, apraxia and walking within minutes after treatment at the INR in Boca Raton, Florida.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Rapid Improvement in Walking, Balance, Tone & Cognition 3 Years After Stroke

From Kentucky to the INR in Boca Raton, Florida. Published July 16, 2018.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

“Perispinal etanercept advances as a neurotherapeutic” published in Expert Review of Neurotherapeutics April 2018

Invited editorial by Edward Tobinick, MD, entitled, “Perispinal etanercept advances as a neurotherapeutic” published in Expert Review of Neurotherapeutics, on April 25, 2018.

Walking without cane after treatment from Scotland to the INR Boca Raton, April 2018

Walking without a stick (cane) after treatment at the INR! Eddie and his family from Scotland, visiting the INR Boca Raton, on April 23, 2018.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

From Denmark to the INR in Boca Raton, Florida, March 2018. Immediate and sustained improvement, two years after traumatic brain injury from a skiing accident.

She has written an update on her progress! See it here!

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Immediate Improvement in Vision after Treatment at the INR Boca Raton, April 10, 2018

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Many Rapid Improvements 2 years after Stroke, from Iceland to the INR, March 9, 2018

Patient and father, from Iceland, discusses improvements 2 years after stroke. The stroke happened at age 17. Improvements discussed include: spasticity, left neglect, walking, speech, fatigue, and improved ability to swallow.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Immediate improvement 22 months after stroke, at the INR, on March 6, 2018

Treatment at the Institute of Neurological Recovery in Boca Raton, Florida, March 6, 2018, twenty two months after stroke. Immediate improvements in aphasia, apraxia of speech, walking, etc.

Request a consultation today | Terms of Use & Disclaimer

From Papua New Guinea, Dancing 2 Years After Stroke, at the INR, January 2018

Click here to see Part 1.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use